One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk patients preserves ischaemic benefits and reduces bleeding risk. That’s the finding
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
